Top

Published in:

01-02-2010 | Original Article

Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells

Authors: C. Walter, M. O. Klein, A. Pabst, B. Al-Nawas, H. Duschner, T. Ziebart

Published in: Clinical Oral Investigations | Issue 1/2010

Abstract

Bisphosphonate-associated osteonecrosis of the jaws (BP-ONJ) is a side effect primarily in patients receiving highly potent nitrogen-containing bisphosphonates. The exact etiopathology is unknown. In addition to reduced bone remodeling, there may also be an impact on soft tissues. The impact of nitrogen- (ibandronate, pamidronate, zoledronate) and non-nitrogen-containing bisphosphonates (clodronate) on human umbilicord vein endothelial cells (HUVEC), fibroblasts and osteogenic cells was analyzed employing cell viability testing and a scratch wound assay. The impact on the cell morphology of vital-stained osteogenic cells was investigated by cell visualization (confocal laser scanning microscopy). Pamidronate and zoledronate had the greatest negative impact on all cell lines, whereas the impact of ibandronate and clodronate was less distinct. The effect of clodronate on HUVEC and fibroblasts was particularly marginal. BP-ONJ could be a multifactorial event with multicellular impairments. This might result in altered wound healing. The increased impact of the highly potent bisphosphonates, particularly on non-bone cells, may explain the higher occurrence of BP-ONJ.

Diel IJ, Bergner R, Grotz KA (2007) Adverse effects of bisphosphonates: current issues. J Support Oncol 5(10):475–482PubMed

Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115–1117CrossRefPubMed

Walter C, Grotz KA, Kunkel M et al (2007) Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. Support Care Cancer 15(2):197–202CrossRefPubMed

Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws AAoOaMS (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65(3):369–376CrossRef

Hoff AO, Toth BB, Altundag K et al (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23(6):826–836CrossRefPubMed

Aguiar Bujanda D, Bohn Sarmiento U, Cabrera Suarez MA et al (2007) Assessment of renal toxicity and osteonecrosis of the jaws in patients receiving zoledronic acid for bone metastasis. Ann Oncol 18(3):556–560CrossRefPubMed

Boonyapakorn T, Schirmer I, Reichart PA et al (2008) Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 44(9):857–869CrossRefPubMed

Wang EP, Kaban LB, Strewler GJ et al (2007) Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 65(7):1328–1331CrossRefPubMed

Walter C, Al-Nawas B, Grotz KA et al (2008) Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol 54(5):1066–1072CrossRefPubMed

10.

Rizzoli R, Burlet N, Cahall D et al (2008) Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 42(5):841–847CrossRefPubMed

11.

Walter C, Al-Nawas B, Wagner W (2008) Implantology as a reason for bisphosphonate-associated-osteonecrosis of the jaws (BP-ONJ). Clin Oral Implants Res 19(9):850

12.

Mashiba T, Mori S, Burr DB et al (2005) The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib. J Bone Miner Metab 23(Suppl):36–42CrossRefPubMed

13.

Santini D, Vincenzi B, Avvisati G et al (2002) Pamidronate induces modifications of circulating angiogenetic factors in cancer patients. Clin Cancer Res 8(5):1080–1084PubMed

14.

Allegra A, Oteri G, Nastro E et al (2007) Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells. Hematol Oncol 25(4):164–169CrossRefPubMed

15.

Ziebart T, Yoon CH, Trepels T et al (2008) Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia. Circ Res 103(11):1327–1334CrossRefPubMed

16.

Landesberg R, Cozin M, Cremers S et al (2008) Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg 66(5):839–847CrossRefPubMed

17.

Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63CrossRefPubMed

18.

Kim HJ, Kim SH, Kim MS et al (2005) Varying Ti-6Al-4V surface roughness induces different early morphologic and molecular responses in MG63 osteoblast-like cells. J Biomed Mater Res A 74(3):366–373PubMed

19.

Park BS, Heo SJ, Kim CS et al (2005) Effects of adhesion molecules on the behavior of osteoblast-like cells and normal human fibroblasts on different titanium surfaces. J Biomed Mater Res A 74(4):640–651PubMed

20.

Klein MO, Tapety F, Sandhöfer F et al (2006) Visualization of vital osteogenic cells on differently treated titanium surfaces using confocal laser scanning microscopy (CLSM)—a pilot study. Z Zahnärztl Implantol 21(4):145–153

21.

Mashiba T, Hirano T, Turner CH et al (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15(4):613–620CrossRefPubMed

22.

Rogers MJ, Watts DJ, Russell RG (1997) Overview of bisphosphonates. Cancer 80(8 Suppl):1652–1660CrossRefPubMed

23.

Marx RE, Sawatari Y, Fortin M et al (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63(11):1567–1575CrossRefPubMed

24.

Reszka AA, Halasy-Nagy J, Rodan GA (2001) Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation. Mol Pharmacol 59(2):193–202PubMed

25.

Reid IR, Bolland MJ, Grey AB (2007) Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 41(3):318–320CrossRefPubMed

26.

Fleisch H (2003) Bisphosphonates in osteoporosis. Eur Spine J 12(Suppl 2):S142–S146CrossRefPubMed

27.

Rogers MJ, Gordon S, Benford HL et al (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88(12 Suppl):2961–2978CrossRefPubMed

28.

Huja SS, Fernandez SA, Hill KJ et al (2006) Remodeling dynamics in the alveolar process in skeletally mature dogs. Anat Rec A Discov Mol Cell Evol Biol 288(12):1243–1249PubMed

29.

Ruggiero SL, Mehrotra B, Rosenberg TJ et al (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62(5):527–534CrossRefPubMed

30.

Marx RE, Cillo JE Jr, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65(12):2397–2410CrossRefPubMed

31.

Montazeri AH, Erskine JG, McQuaker IG (2007) Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma. Eur J Haematol 79(1):69–71CrossRefPubMed

Title: Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells
Authors: C. Walter
M. O. Klein
A. Pabst
B. Al-Nawas
H. Duschner
T. Ziebart
Publication date: 01-02-2010
Publisher: Springer-Verlag
Published in: Clinical Oral Investigations / Issue 1/2010
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-009-0266-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation

Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature

Undesirable and adverse effects of tooth-whitening products: a review

Two modifications in the treatment of keratocystic odontogenic tumors (KCOT) and the use of Carnoy’s solution (CS)—a retrospective study lasting between 2 and 10 years

Adoption of a toothbrushing technique: a controlled, randomised clinical trial

Anabolic effect of intermittent PTH(1-34) on the local microenvironment during the late phase of periodontal repair in a rat model of tooth root resorption